CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-17 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +90,766 | 90,766 | ||
| 2020-06-17 | Yi Qingqing Director | Grant or award · Share Option (Right to Buy) | −45,383 | 45,383 | ||
| 2020-06-10 | OYLER JOHN Chief Executive Officer | Sale | −900 | $175.07 | $158K | 0 |
| 2020-06-08 | Liang Howard CFO & Chief Strategy Officer | Sale | −453 | $170.84 | $77K | 0 |
| 2020-06-08 | Wu Xiaobin President & GM China | Sale | −1,200 | $170.02 | $204K | 1,600 |
| 2020-06-08 | Wu Xiaobin President & GM China | Sale | −1,125 | $171.20 | $193K | 475 |
| 2020-06-08 | Wu Xiaobin President & GM China | Sale | −475 | $171.98 | $82K | 0 |
| 2020-06-08 | Huang Jane CMO, Hematology | Sale | −631 | $170.84 | $108K | 0 |
| 2020-06-08 | Wang Xiaodong Director | Sale | −3,500 | $170.48 | $597K | 2,500 |
| 2020-06-08 | Wang Xiaodong Director | Sale | −2,300 | $171.42 | $394K | 200 |
| 2020-06-08 | Wang Xiaodong Director | Sale | −200 | $172.46 | $34K | 0 |
| 2020-05-29 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $29.49 | $44K | 1,500 |
| 2020-05-29 | Huang Jane CMO, Hematology | Sale | −500 | $162.63 | $81K | 1,000 |
| 2020-05-29 | Huang Jane CMO, Hematology | Sale | −569 | $163.97 | $93K | 431 |
| 2020-05-29 | Huang Jane CMO, Hematology | Sale | −431 | $165.12 | $71K | 0 |
| 2020-05-29 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 480,575 | ||
| 2020-05-19 | Glazer Donald W. Director | Gift | −2,680 | 3,497,678 | ||
| 2020-05-19 | Glazer Donald W. Director | Sale | −10,000 | $169.84 | $1.7M | 0 |
| 2020-05-01 | OYLER JOHN Chief Executive Officer | Sale | −1,000 | $142.46 | $142K | 3,635 |
| 2020-05-01 | OYLER JOHN Chief Executive Officer | Sale | −302 | $143.17 | $43K | 3,333 |
Page 94 of 99 · 1,972 trades